PTJ
ARKG icon

Paul Tudor Jones’s ARK Genomic Revolution ETF ARKG Stock Holding History

Paul Tudor Jones’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11M Buy
+26,477
New +$843K ﹤0.01% 2345
2024
Q3 		– Sell
-28,682
Closed -$673K – 2684
2024
Q2 		$673K Buy
+28,682
New +$724K ﹤0.01% 1666

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Paul Tudor Jones's ARKG Position: Q2 2026 in Review

Paul Tudor Jones opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 26,477 shares worth $1.11M. The stake represents ﹤0.01% of the portfolio and ranks #2345 among its holdings. This is a return to the name: Paul Tudor Jones previously reported a position in ARKG as recently as Q2 2024.

Paul Tudor Jones first reported a position in ARKG in Q2 2024 and has held it in 2 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Paul Tudor Jones held 26,477 shares of ARK Genomic Revolution ETF worth $1.11M as of Q2 2026.
  • ARK Genomic Revolution ETF was a new Paul Tudor Jones position in Q2 2026.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #2345 holding.
  • Paul Tudor Jones first reported a position in ARK Genomic Revolution ETF in Q2 2024 and has held it in 2 quarters since.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.